Contact: [email protected]

Statewide

State of Hawaiʻi Department of Health, Emergency Medical Services & Injury Prevention System Branch

Current69 dose entries25 drugs1 documentHonolulu, HIeffective 2025-06-10100% machine-parsed of 69

Drugs and doses25

A–C Acetaminophen, Albuterol, Aspirin, Calcium Gluconate, Cefazolin5

Acetaminophen

IndicationPopulationDoseRouteRepeatStandingSource
Other peds 15 mg/kg PO not captured standing page 141 · source

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 5 mg NEB not captured standing pages 81, 144 · source
Allergic reaction peds 5 mg NEB not captured standing pages 81, 144 · source
Asthma / bronchospasm adult 5 mg NEB not captured standing pages 112, 155, 156 · source
Asthma / bronchospasm peds 2.5 mg NEB not captured standing pages 112, 155, 156 · source

Aspirin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 325 mg PO not captured standing page 63 · source

Calcium Gluconate

IndicationPopulationDoseRouteRepeatStandingSource
Hyperkalemia adult 10 mL IV/IO not captured standing page 67 · source

Cefazolin

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2000 mg IV/IO not captured standing pages 1, 57, 126, 163 · source
Other peds 30 mg/kg IV/IO not captured standing pages 1, 57, 126, 163 · source
D–F Diazepam, Diphenhydramine, Epinephrine, Etomidate, Fentanyl5

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5 mg IV/IM not captured standing page 74 · source
Seizure adult 5 mg IV not captured standing pages 76, 139, 140 · source
Seizure peds 0.1 mg/kg IV not captured standing pages 76, 139, 140 · source

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 25–50 mg IV/IM/PO not captured standing pages 80, 82, 143, 146 · source
Allergic reaction peds 1 mg/kg IV/IM/PO not captured standing pages 80, 82, 143, 146 · source

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 0.3 mg IM not captured standing pages 80, 81, 144, 145 · source
Anaphylaxis peds 0.01 mg/kg IM not captured standing pages 80, 81, 144, 145 · source
Asthma / bronchospasm adult 0.3 mg IM not captured standing pages 113, 155, 157 · source
Asthma / bronchospasm peds 0.01 mg/kg IM not captured standing pages 113, 155, 157 · source
Asthma / bronchospasm peds 0.01 mg/kg ET not captured standing pages 157, 158 · source
Neonatal resuscitation peds 0.3 mL/kg IV/IO not captured standing pages 153, 154 · source
Neonatal resuscitation peds 0.5–1 mL/kg ET not captured standing pages 153, 154 · source

Etomidate

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 0.3 mg/kg IV/IO not captured standing page 33 · source
RSI induction peds 0.3 mg/kg IV/IO not captured standing page 33 · source

Fentanyl

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 50 mcg IV not captured standing page 34 · source
Mild to moderate pain adult 50 mcg IV/IM/IN not captured standing pages 27, 28 · source
Mild to moderate pain peds 0.5 mcg/kg IV/IM/IN not captured standing pages 27, 28 · source
G–L Glucagon, Ipratropium, Levalbuterol, Lorazepam4

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 1 mg IM not captured standing pages 99, 152 · source
Hypoglycemia peds 1 mg IM not captured standing pages 99, 152 · source

Ipratropium

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 0.5 mg NEB not captured standing pages 81, 144 · source
Allergic reaction peds 0.5 mg NEB not captured standing pages 81, 144 · source
Asthma / bronchospasm adult 0.5 mg NEB not captured standing pages 112, 155, 156 · source
Asthma / bronchospasm peds 0.25 mg NEB not captured standing pages 112, 155, 156 · source

Levalbuterol

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2.5 mg NEB not captured standing pages 81, 112, 156 · source
Asthma / bronchospasm peds 1.25 mg NEB not captured standing pages 81, 112, 156 · source

Lorazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 2 mg IV/IM not captured standing page 73 · source
Seizure adult 2 mg IV not captured standing pages 76, 77, 139, 140 · source
Seizure peds 0.05 mg/kg IV not captured standing pages 76, 77, 139, 140 · source
M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxytocin9

Magnesium Sulfate

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2 g IV not captured standing pages 113, 157 · source
Asthma / bronchospasm peds 50 mg/kg IV not captured standing pages 113, 157 · source
Eclampsia / pre-eclampsia adult 4 g IV not captured standing page 107 · source

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 2 mg IV not captured standing pages 72, 73 · source
Agitation adult 5 mg IM not captured standing pages 72, 73 · source
Agitation adult 5 mg IN not captured standing pages 72, 73 · source
Eclampsia / pre-eclampsia adult 2 mg IV/IO/IM/IN not captured standing page 108 · source
Procedural sedation adult 2–2.5 mg IV/IO/IM/IN not captured standing page 15 · source
RSI induction adult 0.1 mg/kg IV/IO not captured standing pages 33, 34 · source
RSI induction peds 0.1 mg/kg IV/IO not captured standing pages 33, 34 · source
Seizure adult 10 mg IM/IN not captured standing page 75 · source
Seizure adult 2 mg IV not captured standing pages 77, 138 · source
Seizure peds 0.1 mg/kg IV not captured standing pages 77, 138 · source
Seizure peds 0.1 mg/kg IM not captured standing pages 137, 138 · source
Seizure peds 0.2 mg/kg IM/IN not captured standing page 75 · source

Morphine

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 2 mg IV/IM not captured standing page 27 · source

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.4–2 mg IV/IO/IN not captured standing pages 68, 69, 121, 162 · source
Other adult 0.5 mg IV not captured standing page 29 · source
Other peds 0.1 mg/kg IV/IO/IN not captured standing pages 68, 69, 121, 162 · source

Nitroglycerin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.4 mg SL not captured standing pages 62, 63 · source

Norepinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 4–12 mcg IV not captured standing pages 64, 65 · source

Ondansetron

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 4 mg SL not captured standing pages 94, 149 · source
Other adult 4 mg IV not captured standing pages 94, 150 · source
Other peds 0.1 mg/kg IV not captured standing pages 94, 150 · source
Other peds 2–4 mg SL not captured standing pages 94, 149 · source

Oral Glucose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 12–30 g PO not captured standing pages 99, 151 · source
Hypoglycemia peds 12–30 g PO not captured standing pages 99, 151 · source

Oxytocin

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 20 unit IV not captured standing page 106 · source
S–Z Sodium Bicarbonate, Succinylcholine2

Sodium Bicarbonate

IndicationPopulationDoseRouteRepeatStandingSource
Hyperkalemia adult 1 mEq/kg IV/IO not captured standing page 67 · source
Hyperkalemia peds 1 mEq/kg IV/IO not captured standing page 67 · source

Succinylcholine

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 2 mg/kg IV/IO not captured standing pages 33, 35 · source
RSI induction peds 2 mg/kg IV/IO not captured standing pages 33, 35 · source
Cite this

State of Hawaiʻi Department of Health, Emergency Medical Services & Injury Prevention System Branch, United States EMS Protocol Census. 69 dose entries, effective 2025-06-10.

https://protoquiz.com/census/agencies/state-of-hawai-i-department-of-health-emergency-medical-services-injury-prevention-system-branch/

Outdated or wrong? Fix or remove itAll Hawaii agenciesMethodologyData licenseStudy these protocols in the app

The census is free and not for sale. Only public agencies are named.

Training reference compiled from published protocols. Not a clinical order. Verify with your agency and medical director.